Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

OHSU researchers produce first animal model for stress-induced movement disorder

02.04.2003


Research helps physicians understand rare form of ataxia that causes patients to appear ’drunk’ at times


Scientists at Oregon Health & Science University are the first to produce an animal model for episodic ataxia. The condition causes patients to suffer bouts of extreme clumsiness where they have balance, speech and motor difficulties. The research helps scientists better understand this rare and intriguing disorder. It may also help provide valuable information for improved, targeted drugs for treatment. The research is printed in the April edition of the journal Nature Neuroscience. It was conducted in conjunction with researchers at the Portland Veterans Affairs Medical Center.

"By developing a mouse model for episodic ataxia, we now have a valuable tool to better understand and treat the disease," said James Maylie, Ph.D., a professor of obstetrics and gynecology in the OHSU School of Medicine. "We have already used this animal model to observe and learn more about cellular mechanisms behind the disease. These disease-linked cells are located in the cerebellum, a portion of the brain involved in motor coordination."

The research also helps explain how a medication commonly used to treat patients works. "Acetazolamide is often given to patients with episodic ataxia," Maylie said. "Using these mice models, we were able to establish how acetazolamide acts at a cellular level to combat the disorder, something that was previously unknown."



Approximately 150,000 Americans are affected by the various forms of ataxia. The disorder is characterized by poor motor coordination. Specifically, it can cause hand coordination problems, poor balance and slurred speech. People with ataxia are often accused of acting drunk. In most ataxia disorders, the coordination problems are present all the time. In episodic ataxia, the coordination problems come on suddenly, often in stressful situations, and last for minutes or hours.

"Episodic ataxia is one form of the condition involving intermittent spells where sufferers simply can’t control their limbs," said John Nutt, M.D., director of the Parkinson Center of Oregon, which also treats patients with ataxia. "These attacks can last anywhere from a couple of minutes to three or four hours, and they are often triggered by stress, exercise or vigorous activity. In between episodes, patients are completely normal. Episodic ataxia is frequently caused by genetic mutations, but in some cases, multiple sclerosis can be the cause."

Years ago Nutt and his colleagues helped define clinical features of what they thought were three different types of inherited episodic ataxia while working with families seen in the OHSU neurogenetics clinic. In 1994 OHSU researchers Michael Litt, Ph.D., professor of molecular and medical genetics in the OHSU School of Medicine, and research associate David Browne, Ph.D., determined that the disease was caused in some families by a mutation in a gene that controls the flow of potassium in and out of nerve cells. This was the first human disease linked to the malfunction of a potassium gene. Testing all the families with this disorder in the neurogenetics clinic proved that two genes, and not three genes as the clinicians had thought, were responsible for the episodic ataxias. Subsequently other investigators found that a second variant of episodic ataxia was caused by a mutation in a gene that controlled the flow of calcium through the cell membrane.


This research was funded by the National Institute of Neurological Disorders and Stroke, a component of the National Institutes of Health, and the National Ataxia Foundation.

Jim Newman | EurekAlert!
Further information:
http://www.ohsu.edu/

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

Im Focus: Computer-Designed Customized Regenerative Heart Valves

Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...

Im Focus: Light-induced superconductivity under high pressure

A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.

Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Supersonic waves may help electronics beat the heat

18.05.2018 | Power and Electrical Engineering

Keeping a Close Eye on Ice Loss

18.05.2018 | Information Technology

CrowdWater: An App for Flood Research

18.05.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>